Investors & Media

What's new.

E-Mail

registration.

Please fill in ...

Please calculate 4 plus 8.

 

Press releases

Press releases.

Commercial Manufacturing of Eftilagimod Alpha at 2000L Scale Granted Authorization for Clinical Trial Use

September 21st 2023
press releases

Immutep to Participate in September Investor Conferences

September 5th 2023
press releases

Immutep Receives Positive Scientific Advice from European Medicines Agency

August 1st 2023
press releases
more

Investor updates

Investor updates.

Investor Update - August 2023

August 18th 2023
investor updates

Investor Update - November 2022

November 17th 2022
investor updates

Investor Update ASCO 2022 Special Edition June 2022

June 17th 2022
investor updates
more

Analyst reports

Analyst reports.

goetzpartners securities - Fully exploiting LAG3 oncology game changer. Reit Buy, A$2.88 tgt (Dr Chris Redhead)

This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail clients.

September 13th 2023
analyst reports

CLSA - FY24 a pivotal year with key readouts ahead and cash runway to CY26. Mtn Buy, A$0.95 Tgt (Analyst: Andrew Paine)

For a copy of this research report please contact your CLSA advisor

September 10th 2023
analyst reports

Jefferies - FY23: I Say A Little Prayer; Mtn Buy and A$1 tgt (Analyst: Dr David Stanton)

For a copy of this research report please contact your Jefferies advisor

August 31st 2023
analyst reports
more